Ipca Laboratories Limited
IPCALAB
Rank in Stocks
#3272
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Share Price
$21.24
Market Cap
$5.39B
Change (1 day)
6.09%
Change (1 year)
45.94%
Country
IN
Trade Ipca Laboratories Limited (IPCALAB)
Category
Healthcare
Stock price history for Ipca Laboratories Limited (IPCALAB)
Highest end of day price: $21.08 on 2026-10-01
Lowest end of day price: $0.09 on 1996-01-01
Lowest end of day price: $0.09 on 1996-01-01
Stock price history of Ipca Laboratories Limited from 1996 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | 11.41% |
| 2025 | -13.23% |
| 2024 | 38.48% |
| 2023 | 27.11% |
| 2022 | -23.07% |
| 2021 | -9.79% |
| 2020 | 89.81% |
| 2019 | 41.72% |
| 2018 | 27.54% |
| 2017 | 9.85% |
| 2016 | -29.56% |
| 2015 | -1.24% |
| 2014 | 3.97% |
| 2013 | 24.31% |
| 2012 | 74.85% |
| 2011 | -31.23% |
| 2010 | 70.55% |
| 2009 | 196.37% |
| 2008 | -55.33% |
| 2007 | 35.03% |
| 2006 | 33.17% |
| 2005 | -5.25% |
| 2004 | 46.12% |
| 2003 | 294.98% |
| 2002 | 90.18% |
| 2001 | -30.77% |
| 2000 | -57.08% |
| 1999 | 391.04% |
| 1998 | -1.48% |
| 1997 | 26.94% |
| 1996 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 21.02% |
DE
|
|
| $41.46 | 47.41% |
JP
|
|
| $212.49 | 23.19% |
CH
|
|
| $19.19 | -0.09% |
IN
|
